Det danske biotekselskab Dermtreat har haft sine fremtidsplaner oppe til overvejelse og vil ikke længere arbejde frem mod en børsnotering i kølvandet på afslutningen af et netop igangsat fase 2b-studie med sit hovedaktiv, mundplasteret Rivalin.
I stedet vil selskabet fortsætte udviklingen af Rivalin for derved at øge selskabets værdi, før en børsnotering gennemføres.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from AMWatch
AMWatch closed on Friday, May 13
The AMWatch editorial team is taking the day off on Friday, which is a bank holiday for most of our staff.
Danish pension fund drops nuclear weapons investments after member pressure
After Danish media outlets revealed that four Danish pension companies invest in nuclear weapons, members at Lægernes Pension pressured the fund to divest, citing a 2017 UN treaty. The man behind these efforts hopes others will follow suit.
Länsförsäkringar brings index funds home but keeps eyes on Paris
The Swedish insurer has changed to Paris-aligned indices which the firm believes will cut the CO2 emissions of the portfolio in half.
Danish FSA issues warning over SFDR implementation
The Danish FSA, Finanstilsynet, states that asset managers are using the EU’s sustainable finance disclosure regulation to signify quality, which is not the point of the legislation. In fact, the FSA states it is the opposite of what the EU intended.
Japanese investment giant picks Foxberry's ETF platform
Foxberry, an investment indices provider established by a group of Swedes who have previously worked at Nomura, notes that Nomura’s Next Funds brand is on a quick growth trajectory.
Product Specialist, Corporate Credits 
Vi søger projektledere som vil være med til at præge den grønne omstilling og udvikle forretningsområdet ”Bæredygtig Energi” 
Privatkunderådgiver - Connect Privat 
Intern Revisionschef til Købstædernes Forsikring 
Boligchef til solid lokalbank i vækst